TrialClinical cancer research : an official journal of the American Association for Cancer Research2020

A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART SWOG 1609) in Patients with Nonpancreatic Neuroendocrine Tumors.

Sandip P Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.